Javascript must be enabled to continue!

Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

Fourteen patients with uncomplicated essential hypertension and mild asthma were treated with Atenolol 50-125 mg/day for up to 8 months. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), rate pressure index (RPI), stress testing time (STT) and peak expiratory flow rate (PEFR) were measured before, during and after stress testing (ST) before and during treatment. Atenolol significantly lowered HR, SBP, DBP and RPI. It prolonged STT and had no effect on PEFR. Furthermore, Atenolol did not worsen the patient's asthma except for one patient. The drug did not interfere with the bronchodilatation effect of salbutamol. Atenolol can be used cautiously to treat hypertension in asthmatic patients under certain conditions.

SAGE Publications

Shimon Krauss Edward Spitz Agota Krauss Bronja Grizotzki Sinai Clement

Angiology

2007

Title: Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

Description:

Fourteen patients with uncomplicated essential hypertension and mild asthma were treated with Atenolol 50-125 mg/day for up to 8 months.

Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), rate pressure index (RPI), stress testing time (STT) and peak expiratory flow rate (PEFR) were measured before, during and after stress testing (ST) before and during treatment.

Atenolol significantly lowered HR, SBP, DBP and RPI.

It prolonged STT and had no effect on PEFR.

Furthermore, Atenolol did not worsen the patient's asthma except for one patient.

The drug did not interfere with the bronchodilatation effect of salbutamol.

Atenolol can be used cautiously to treat hypertension in asthmatic patients under certain conditions.

Back

Objectives Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...

Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension

Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...

Comparative study of atenolol in human plasma by high performance liquid chromatography and capillary zone electrophoresis

Atenolol is a beta-blocker that is cardioselective, meaning it only affects beta receptors. It is used to treat angina pectoris and high blood pressure. The HPLC and Capillary Zone...

Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials

Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

TRANSDERMAL OF ATENOLOL VIA MICROEMULSIONS

Objective: Developing novel non-ionic microemulsions (MEs) for transdermal of atenolol as satisfactory alternative drug delivery systems for the oral route. Methods: Seven MEs wer...

Evaluating the pharmacokinetic parameters of a single dose of oral disintegrating tablets in elderly patients with hypertension and hyperlipidemia

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, particularly in underprivileged areas such as Pakistan. Hypertension and hyperlipidemia are major risk fact...

Respiratory muscle strength in asthmatic children

Introduction: Changes in the respiratory system of asthmatics are also due to the mechanical disadvantage caused by the increased airway resistance. Objective: The stud...

Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review

Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

Email:
Password:

Email:

Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

Related Results